C difficile: Summer 2025 Clinical Recap

News
Article

A June–September C diff roundup spanning diagnostics and stewardship debates, microbiome-based therapies and FMT optimization, prevention trials and funding, real-world outcomes, and persistent gaps in clinician practice and public awareness.

June

Evolving Challenges in C difficile Testing: Diagnostic Stewardship or Laboratory Retrogression?
Study questions added value of enzyme immunoassays alongside PCR, citing sensitivity concerns and clinical impact.

Outpatient C difficile Cases Reveal Diagnostic Gaps and PPI-Linked Risks
ASM Microbe data emphasize NAAT’s role in outpatient CDI diagnosis and spotlight PPI-associated risk in older patients.

AI Tool Demonstrates Potential to Support Antimicrobial Stewardship and Reduce C difficile in Hospitals
An AI-guided infection-prevention bundle increased stewardship activity despite no significant CDI incidence reduction.

July

Real-World Use of Fecal Microbiota, Live-Jslm Shows High Success in Preventing Recurrent C difficile Infection
Multicenter US experience supports RBL as a safe, effective microbiota-based option with sustained rCDI remission.

Effectiveness of Oral Vancomycin in Preventing C difficile Remains Uncertain After Trial
Randomized data leave the role of prophylactic oral vancomycin for CDI prevention unresolved in at-risk patients.

A Young Mother With C difficile Deals With Social Isolation, Concerns of Recurrence
Patient perspective details CDI during pregnancy, recovery challenges, and peer-support resources through the Peggy Lillis Foundation.

Study Explores Therapeutic Approaches to Enhance FMT Success in C difficile Treatment
Multidose capsules or colonoscopy after extended antibiotic pretreatment yield the highest FMT success rates for rCDI.

August

Can We Predict and Prevent C difficile Colonization?
Personalized gut microbiome modeling may identify CDI colonization risk and guide targeted probiotic interventions.

Antibiotic Stewardship Alone May Be Insufficient for Preventing C Diff Infections
Colonization status drives hospital-onset CDI risk, suggesting prevention must pair stewardship with targeted colonization control.

Microbiota-Based Therapies Show Superior Outcomes for Recurrent C difficile Infection
Systematic review finds FMT and standardized microbiome products outperform antibiotics for rCDI efficacy and safety.

No Shortcuts With C difficile: What Electronic Hand Hygiene Reminders Tell Us About Hand Washing Prevention
Electronic prompts improve adherence but reinforce that consistent, thorough hand hygiene remains central to CDI prevention.

September

LPOXY Secures $28M to Launch Pivotal STOP-Cdiff Trial for C difficile Prevention
New funding advances a pivotal prophylaxis study aiming to reduce CDI incidence in high-risk populations.

Guideline Vs Reality: Survey of Clinician Preferences in the Management of Clostridioides difficile Infection in Adults Highlights Barriers to Optimal Care
Clinician responses reveal departures from guideline-concordant CDI management and identify practical barriers to optimal diagnosis and treatment.

National Survey Shows More Than Half of Respondents Were Not Aware of C difficile
Despite rising awareness, gaps persist, underscoring the need for public education on C difficile transmission, risk, and prevention.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.